Uterine rupture as a complication of second-trimester abortion when using prostaglandin F2 alpha together with other oxytocic agents.
A case of uterine rupture is presented following induction of second-trimester abortion using oxytocin and prostaglandin F2 alpha. A brief review of the literature is given and etiological factors and diagnostic features are discussed.
D000032:Abortion, Therapeutic; D000328:Adult; D000650:Amnion; D015237:Dinoprost; D005260:Female; D006801:Humans; D007267:Injections; D010121:Oxytocin / Q000008:administration & dosage / Q000009:adverse effects*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011460:Prostaglandins F / Q000008:administration & dosage / Q000009:adverse effects*; D014597:Uterine Rupture / Q000209:etiology*
D011460:Prostaglandins F; D010121:Oxytocin; D015237:Dinoprost